BioLife Solutions CTO Sean Werner Reports Major Stock Moves
Sean Werner, CTO of BioLife Solutions, reports significant stock transactions following the merger with Repligen Corporation, impacting shareholder dynamics.
CFO John Walter Hazlett Boosts Stake in Willamette Valley Vineyards
CFO John Walter Hazlett increases his stake in Willamette Valley Vineyards through multiple stock acquisitions, signaling confidence in the company.
Chen Xiaoping Alters Shareholdings in Viomi Technology
Chen Xiaoping has restructured his shareholdings in Viomi Technology Co., Ltd, impacting the household appliances sector and setting a precedent for competitors.
AgomAb Therapeutics NV director purchases 5,000 shares
AgomAb Therapeutics NV's David R. Epstein buys 5,000 shares, indicating confidence in the company's prospects in the biological products sector.
Wichterman Troy Reports Major Stock Transactions Post-Merger
Wichterman Troy, CFO of BioLife Solutions, discloses significant stock transactions following a merger, highlighting industry consolidation trends.
Berard Todd Reports Stock Transactions After BioLife Merger
Berard Todd, CMO of BioLife Solutions, discloses stock transactions following the merger with Repligen, signaling strategic shifts in the electromedical sector.
TRex Bio director Coy Travis Alan exercises stock options
TRex Bio, Inc. director Coy Travis Alan exercises stock options, signaling the company's commitment to talent retention in the biological products sector.
TRex Bio grants stock options to Director Giltner
TRex Bio, Inc. grants stock options to Director Carol Giltner, reflecting commitment to leadership incentives in the Biological Products sector.
Retension Pharmaceuticals grants stock options to director
Retension Pharmaceuticals, Inc. grants stock options to director Franklin M. Berger, reflecting its commitment to leadership and talent retention.
TRex Bio grants stock options to director Marcus Joel S
TRex Bio, Inc. has granted stock options to director Marcus Joel S, indicating a commitment to leadership incentives in the biological products industry.
TRex Bio director acquires 17,500 stock options
Julie Ann Gilmore of TRex Bio, Inc. reports acquisition of 17,500 stock options, reflecting the company's strategy to incentivize leadership.
Newton Tyler Amends SEC Filing to Correct Stock Holdings
Newton Tyler amends SEC filing to clarify stock holdings in Weave Communications, correcting previous errors regarding shares and restricted stock units.
Catherine Coste Disposes of Shares Following BioLife Merger
Catherine Coste sells 13,871 shares of BioLife Solutions post-merger with Repligen, signaling shifts in the electromedical sector.
Shwed Gil Reports Share Transactions for Check Point Software
Shwed Gil's recent share transactions for Check Point Software Technologies highlight ownership changes in the software services sector.
Saxe Timothy Reports Change in Beneficial Ownership
Saxe Timothy has filed a Form 4, reporting changes in beneficial ownership of securities, reflecting ongoing activity in the semiconductor industry.
BioLife Solutions CEO Roderick De Greef Reports Stock Moves
Roderick De Greef, CEO of BioLife Solutions, discloses stock transactions following a merger, indicating significant changes in executive ownership.
DuRoss Amy sells shares post-BioLife Solutions merger
Amy DuRoss reports sale of shares after BioLife Solutions' merger with Repligen Corporation, indicating a shift in ownership dynamics.
TRex Bio grants stock options to director Ross Michael Jay
TRex Bio, Inc. grants stock options to director Ross Michael Jay, reflecting a strategic move to incentivize leadership in the biological products industry.
Schneider National director acquires shares in recent filing
James Giertz, a director at Schneider National, recently acquired shares through a deferred compensation program, highlighting executive engagement.
Teamshares Inc. Director Reports Stock Acquisition
Teamshares Inc. director Adam J. Fishman acquires 14,000 shares, signaling commitment to company growth and aligning interests with shareholders.